MedTrace Logo

A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)

NCT02099123 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 9971

Last updated 2024-11-21

No results posted yet for this study

Summary

The STAREE study will examine whether treatment with statin (atorvastatin 40mg) compared with placebo will prolong disability free survival and reduce major cardiovascular events amongst healthy elderly people (≥70 years).

Conditions

  • Independent Living
  • Disability Free Survival
  • Elderly
  • Healthy

Interventions

DRUG

Atorvastatin

Atorvastatin 20 mg tablet

DRUG

Placebo (for Atorvastatin)

Inactive pill manufactured to mimic Atorvastatin 20 mg tablet

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • National Heart Foundation, Australia

    collaborator OTHER

  • Monash University

    lead OTHER

Principal Investigators

  • Sophia Zoungas, MBBS, FRACP · Monash University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02099123 on ClinicalTrials.gov